Abstract Library

#2288 Predicting Resectability of Primary Tumor and Mesenteric Lumps in Patients with Small Intestine Neuroendocrine Tumors

Introduction: Vascular infiltration and mesenteric fibrosis may jeopardize resection of primary tumor (PT) and mesenteric metastatic lumps (MLs) in small-intestine neuroendocrine tumors (SI-NETs).

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Piccioli A, Funicelli L, Fazio N, Borin S, Petz W,

Keywords: small intestine neuroendocrine tumors, mesenteric fibrosis, mesenteric vascular infiltration, resection of primary tumor, mesenteric metastatic lumps, radical surgery,

#1827 Primary Tumor Resection Results in Superior Overall Survival after Peptide Receptor Radionuclide Therapy in Advanced Neuroendocrine Neoplasms

Introduction: Peptide receptor radionuclide therapy (PRRT) is an highly effective therapeutic option to treat advanced neuroendocrine neoplasms (NEN). However, it is still unclear whether resection of primary tumors improves overall survival (OS) after PRRT.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Kaemmerer D

Authors: Kaemmerer D, Twrznik M, Hommann M, Hörsch D, Baum R,

Keywords: PRRT, surgery,

#376 Resection of Primary Tumor Improves Survival in Small Bowel Neuroendocrine Tumors: A Single Center Experience

Introduction: Small bowel neuroendocrine tumors are uncommon tumors with an incidence of <0.5-1 per 100,000 population/year. We report on the survival rates of patients who had the primary tumor resected, to see whether primary tumor removal improves outcome.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Srirajaskanthan R, Ahmed A, O'Sullivan A, Prachialis A, Ramage J,

Keywords: surgery, primary tumor, small bowel, survival, resection,

#375 How Long to Continue Surveillance in Patients Following ‘Curative Resection’ of Primary Small Bowel Tumors?

Introduction: Around 40-50% of patients with small bowel (SB) NETs have metastatic disease at the time of presentation. The majority of the remainder proceed to surgery for attempted curative resection. The optimal duration of surveillance post ‘curative surgical’ resection of primary SB NETs is unknown.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Srirajaskanthan R, Ahmed A, Heaton N, Ramage J,

Keywords: recurrent disease, small bowel, surgery,

#352 Predictive factors of tumor control in patients with well differentiated digestive endocrine carcinomas (WDEC) treated with lanreotide

Introduction: The antiproliferative effect of somatostatin analogs was recently demonstrated.

Conference:

Presenting Author:

Authors: Palazzo M, Lombard-Bohas C, Cadiot G, Matysiak-Budnik T, Rebours V,

Keywords: somatostatin analogs, neuroendocrine, treatment, clinical,